Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2





Top > Articles > Diabetes and Endocrinology  

Web Links
Sort By :
91. Pegvisomant-Somatostatin Analog Treatment Effective Against Acromegaly




The combination of somatostatin analogs (SSA) and pegvisomant (PEG-V) is safe and effective long-term treatment for patients with acromegaly, according to a report in the December issue of The Journal of Clinical Endocrinology & Metabolism. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 11, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

92. FDA Approvals: Glumetza, Nexavar, Micera




The FDA has approved a new strength for metformin HCl extended-release tablets, a new indication for sorafenib tosylate tablets, and methoxy polyethylene glycol-epoetin beta. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 11, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

93. Metformin and Lifestyle Changes Effective in Antipsychotic-Induced Weight Gain




Metformin and lifestyle interventions were effective for antipsychotic-induced weight gain in a randomized trial of adult patients with schizophrenia at a mental health facility in China. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 11, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

94. Ethanol Induces Hypoglycemia by Boosting Islet Blood Flow and Insulin Output




Ethanol intake is well known as a potential cause of hypoglycemia in diabetic patients and now new findings from an animal study shed light on the mechanisms involved, according to a report in the January issue of Endocrinology. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 11, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

95. Glycemic Control Has Improved Recently Among U.S. Diabetics




The percentage of U.S. adults with diabetes who had an glycosylated hemoglobin (A1C) level less than 7% increased during the period 1999-2004, according to findings published in the January issue of Diabetes Care. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 11, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

96. Pinning Down Mortality Rates After Bariatric Surgery




Commentary on a study on mortality rates after bariatric surgery, published October 2007 in the Archives of Surgery
Medscape General Surgery
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 12, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

97. High Intake of Sorbitol in Gum and Sweets May Cause Extreme Weight Loss




Researchers cite 2 patients who suffered severe weight loss from heavy use of sorbitol. WebMD Health News
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 12, 2008 Hits: 2 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

98. Can Fentanyl Patches Be Replaced Sooner to Improve Pain Control?




The approved dosing interval for transdermal fentanyl is 72 hours, but some pain specialists are shortening that period to provide adequate pain relief.
Medscape Pharmacists
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 12, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

99. Variants in Osteoarthritis Gene Locus Linked to Height




Variants in the gene locus GDF5-UQCC associated with osteoarthritis appear to contribute modestly to variations in body height, according to a report in the January 13th online issue of Nature Genetics. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 15, 2008 Hits: 0 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

100. Investigational Agent Taranabant Inhibits Food Intake and Stimulates Metabolism




Taranabant, a novel cannabinoid 1 (CB1) receptor inverse agonist, induces weight loss by reducing appetite and increasing energy expenditure and fat oxidation, according to a compilation of research data presented in the January issue of Cell Metabolism. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology

Date Added: Jan 16, 2008 Hits: 1 Rating: 0.00 Votes: 0
Member Reviews Visitor Ratings Google PR

Pages: [<< First] [< Previous] 5 6 7 8 9 10 11 12 13 14 [Next >] [Last >>]

Category Jump :



Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS